Institute for Cancer Research

Kjetil Taskén
Institute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

See introductory video with welcome to the ICR 

See full video covering all of ICR and its Departments 

Publication overview

Annual reports


Current news and events

Ceremony November 25thDr Ragnar Mørk´s Prize for excellent cancer research 2022 to Marina Vietri

Marina Vietri
Marina Vietri

Marina Vietri from the Department of Molecular Cell Biology is this year's winner of the prestigious Dr. Ragnar Mørk's Prize for cancer research.

She has won the award of NOK 200.000 for her pioneering studies of nuclear envelope sealing in genome integrity and cancer progression.

The prize ceremony took place on 25th of November in the Auditorium of Institute for Cancer Research.

Earlier this year Marina Vietri was awarded the NFR Young Research Talent grant.

Pharmacogenomics to improve transplantation oncology of metastatic colorectal cancer

Anita Sveen and Pål-Dag Line
Anita Sveen and Pål-Dag Line

Molecular biologist Anita Sveen and surgeon Pål-Dag Line join forces in a new project to improve the patient benefit from liver transplantation of metastatic colorectal cancer. This is a collaborative effort between Dept Molecular Oncology (KRE) and Dept Transplantation Medicine (KIT)

The project is a translational substudy of ongoing clinical studies and will generate the first large-scale molecular and pharmacological data of transplantable metastatic colorectal cancers. This project was recently supported by a research grant from the Norwegian Cancer Society.

Maja Radulovic first author on EMBO J article:An ER for damaged lysosomes

Maja Radulovic
Maja Radulovic

Maja Radulovic, postdoc in Harald Stenmark's group at Institute for Cancer Research and Centre for Cancer Cell Reprogramming, has previously shown that a molecular machinery known as ESCRT contributes to repair damaged lysosomes. Now, Maja and her co-workers have revealed an additional mechanism that contributes to lysosome repair, namely lipid transfer from the endoplasmic reticulum (ER). The results are published in the prestigious EMBO Journal, in an article entitled "Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair".

Award ceremony November 3rd:Harald Stenmark awarded Anders Jahre's medical prize for 2022

Harald Stenmark
Harald Stenmark

The University of Oslo announced in June that Anders Jahre's major medical prize for 2022 of NOK 1 million goes to Harald Stenmark, head of the Cellular Membrane Dynamics research group at the Institute for Cancer Research.
The prizes for 2022 will be given out in the University's auditorium on Thursday 3 November at 18:00.
In conjunction with the Award ceremony there are open Jahre Lectures by the Prize winners in a session from 1000-1345 in the down-town university complex (Professorboligen).


Eliminating RNA Immunogenicity via Chemical Modifications: Good to Know

Besides being the physical link between DNA and proteins, RNAs play several other key roles, including RNA catalysis and gene regulation. Recent advances in the delivery and chemical modifications of RNAs have enabled the development of RNA-based therapeutics, including antisense oligonucleotides, ribozymes, small interfering RNAs, and messenger RNAs.
In this essay, group leader Mouldy Sioud goes through recent advances in this field, and how their work is relevant for the development of covid-19 vaccines.